Edwina Baskin-Bey
Director/Board Member at Fight Cancer Global, Llc
Profile
Edwina S.
Baskin-Bey is currently the Executive Director at Fight Cancer Global, Llc.
Prior to this, she held positions as Director at Catalyst Clinical Research LLC, Chief Medical Officer at Nanobiotix SA, Innocrin Pharmaceuticals, Inc., and Oncternal Therapeutics, Inc. She received her undergraduate degree from Hunter College and her doctorate from New York University School of Medicine.
Edwina Baskin-Bey active positions
Companies | Position | Start |
---|---|---|
Fight Cancer Global, Llc
Fight Cancer Global, Llc Information Technology ServicesTechnology Services Fight Cancer Global, LLC provides a network platform aimed at solving the isolation problems faced by cancer patients. The private company is based in Houston, TX. | Director/Board Member | - |
Former positions of Edwina Baskin-Bey
Companies | Position | End |
---|---|---|
ONCTERNAL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2021-05-16 |
NANOBIOTIX | Chief Tech/Sci/R&D Officer | 2020-04-05 |
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | Chief Tech/Sci/R&D Officer | - |
Catalyst Clinical Research LLC
Catalyst Clinical Research LLC BiotechnologyHealth Technology Catalyst Clinical Research LLC engages in the provision of staffing resources to the biotechnology, pharmaceutical and medical device companies. It offers augmented contract staff, monitoring teams, CRO oversight and medical writing services. The company was founded by Betsy Brown and Jean Hendrickson n 2013 and is headquartered in Durham, NC. | Director/Board Member | - |
Training of Edwina Baskin-Bey
Hunter College | Undergraduate Degree |
New York University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
NANOBIOTIX | Health Technology |
ONCTERNAL THERAPEUTICS, INC. | Health Technology |
Private companies | 3 |
---|---|
Catalyst Clinical Research LLC
Catalyst Clinical Research LLC BiotechnologyHealth Technology Catalyst Clinical Research LLC engages in the provision of staffing resources to the biotechnology, pharmaceutical and medical device companies. It offers augmented contract staff, monitoring teams, CRO oversight and medical writing services. The company was founded by Betsy Brown and Jean Hendrickson n 2013 and is headquartered in Durham, NC. | Health Technology |
Fight Cancer Global, Llc
Fight Cancer Global, Llc Information Technology ServicesTechnology Services Fight Cancer Global, LLC provides a network platform aimed at solving the isolation problems faced by cancer patients. The private company is based in Houston, TX. | Technology Services |
Innocrin Pharmaceuticals, Inc.
Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Edwina Baskin-Bey